Novartis prefers a spinoff of its generic drug unit over a potential sale to private equity firms, Bloomberg News reported on Thursday, citing people familiar with the matter. A challenging macro environment for leveraged buyouts has made the sale route difficult and Novartis sees a separate listing of the Sandoz business as more likely, the report said. The Swiss pharmaceutical group in October said it had started a strategic review of the Sandoz unit as price pressures mounted in the off-patent drug sector.
The European Court of Human Rights said Thursday that a complaint against 33 countries filed by six young Portuguese climate activists will be examined by the tribunal's top panel of judges, a move reflecting the case's legal significance. The activists, three of whom are minors, turned to the court almost two years ago in an effort to hold European governments accountable for their allegedly inadequate efforts to cut greenhouse gas emissions. The countries named in the complaint include the 27 member nations of the European Union plus the United Kingdom, Switzerland, Norway, Russia, Turkey and Ukraine.
A lawyer from a small town in eastern Kentucky has joined the fight to protect reproductive rights, a move she didn’t quite expect until she went viral on Twitter — for offering free legal services.